Logo image
Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
Journal article   Open access   Peer reviewed

Nicotinamide riboside is uniquely and orally bioavailable in mice and humans

Samuel A J Trammell, Mark S Schmidt, Benjamin J Weidemann, Philip Redpath, Frank Jaksch, Ryan W Dellinger, Zhonggang Li, E Dale Abel, Marie E Migaud and Charles Brenner
Nature communications, Vol.7(1), 12948
10/10/2016
DOI: 10.1038/ncomms12948
PMCID: PMC5062546
PMID: 27721479
url
https://doi.org/10.1038/ncomms12948View
Published (Version of record) Open Access

Abstract

Nicotinamide riboside (NR) is in wide use as an NAD precursor vitamin. Here we determine the time and dose-dependent effects of NR on blood NAD metabolism in humans. We report that human blood NAD can rise as much as 2.7-fold with a single oral dose of NR in a pilot study of one individual, and that oral NR elevates mouse hepatic NAD with distinct and superior pharmacokinetics to those of nicotinic acid and nicotinamide. We further show that single doses of 100, 300 and 1,000 mg of NR produce dose-dependent increases in the blood NAD metabolome in the first clinical trial of NR pharmacokinetics in humans. We also report that nicotinic acid adenine dinucleotide (NAAD), which was not thought to be en route for the conversion of NR to NAD , is formed from NR and discover that the rise in NAAD is a highly sensitive biomarker of effective NAD repletion.
Biomarkers - metabolism Niacinamide - analogs & derivatives Leukocytes, Mononuclear - metabolism NAD - urine NAD - analogs & derivatives Niacinamide - metabolism Administration, Oral Humans Liver - metabolism Mice, Inbred C57BL Middle Aged Metabolome Vitamins - metabolism Biological Availability Male NAD - blood Niacinamide - administration & dosage Animals Niacinamide - chemistry

Details

Metrics

Logo image